Africa: Vaccines Deliver Over U.S.$30 Billion in Economic Benefits for Lower-Income Countries in 2025
What it is about
Who published it, and when
2 reports left out of the cascade - too little in common with the story to place
How it spread - 6 original reports
Fri, 9 October 2026
1 report- AllAfrica13:20
[GAVI] Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations Recognising the value of immunisation, countries invested a record US$ 301 million in co-financing of Gavi-supported vaccines in 2025 Dr Sania Nishtar, Gavi CEO: "When it comes to immunisation we know that the return on investment extends far beyond health to supporting sustainable, inclusive economic growth."
Thu, 15 October 2026
1 report- AllAfrica07:05
[allAfrica] More than a century after the BCG vaccine was licensed, new tuberculosis vaccines could arrive in 2029. Gavi says the groundwork has to start now.
Thu, 22 October 2026
2 reports- gavi.org11:27first to report
An agreement announced today will cut the price of the RTS,S/AS01 malaria vaccine by approximately 40 per cent. The deal, executed by UNICEF and financially backed by Gavi, the Vaccine Alliance, is expected to generate around US$ 50 million in savings between 2027 and 2029.
- rttnews.com15:31
Gavi and UNICEF have reached an agreement to reduce the price of the RTS,S/AS01 malaria vaccine, marketed as Mosquirix, by about 40%, a move expected to save approximately $50 million between 2027 and 2029.
Sat, 24 October 2026
2 reports- biospectrumindia.com17:15
Bharat Biotech announces equitable pricing for Malaria Vaccine RTS,S/AS01
- biospectrumindia.com17:15
Bharat Biotech announces equitable pricing for Malaria Vaccine RTS,S/AS01